CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Biological intervention: Enteropathogenic E. colibiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00550368
NCT00550368N/ACompleted
CompareCT.gov

Effect of Gastric Acid and H. Pylori Infection on Infection With Enteropathogenic E. Coli

Stanford University·interventional·Posted Oct 29, 2007·Updated Dec 6, 2016

In Brief

A clinical study evaluating Biological intervention: Enteropathogenic E. coli for Infection and Achlorhydria. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfection, Achlorhydria
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 29, 2007
Enrollment StartAug 1, 2005
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 18.7 years ago

Interventions

Biological intervention: Enteropathogenic E. colibiological

5x10\^8 or 1x10\^9 organisms of EPEC were administered to all participants.